Alpha Tau Medical Ltd (DRTS)

Alpha Tau Medical Ltd experienced significant insider selling recently, with Chief Financial Officer Raphi Levy executing multiple divestments totaling approximately $363,150. These transactions occurred following the company's latest earnings report. The stock currently trades near its fifty-two-week high, reflecting a period of notable activity by executive leadership regarding their equity holdings.
Ticker: DRTS Exchange: TLV


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alpha Tau Medical Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
20.93
Quantity 59,473 +45.0%
Value US$344,799
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
463.45
Quantity 3,381 -45.8%
Value US$632,529
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
14.00
Quantity 2,270 -2.5%
Value US$31,782
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
13.23
Quantity 20,000
Value US$264,600
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
13.00
Quantity 17,873 -16.5%
Value US$232,397
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
13.02
Quantity 2,127 -2.3%
Value US$27,691
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
12.58
Quantity 20,000
Value US$251,600
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
12.00
Quantity 20,000 -18.2%
Value US$240,044
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
11.22
Quantity 20,000
Value US$224,400
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
11.00
Quantity 15,778 -12.5%
Value US$173,561
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
11.00
Quantity 4,222 -3.2%
Value US$46,443
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
10.05
Quantity 20,000
Value US$201,000
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
10.00
Quantity 2,500 -1.9%
Value US$25,001
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
9.47
Quantity 15,000 -10.2%
Value US$142,050
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
10.03
Quantity 17,500
Value US$175,525
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
10.76
Quantity 15,000 -9.2%
Value US$161,356
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
10.90
Quantity 17,500 -9.7%
Value US$190,759
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
8.93
Quantity 32,500
Value US$290,225
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
7.40
Quantity 10,000
Value US$73,950
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
6.94
Quantity 87,010
Value US$603,849
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
7.09
Quantity 15,000
Value US$106,350
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
6.41
Quantity 25,000
Value US$160,250
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
5.90
Quantity 61,745
Value US$364,296
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
5.90
Quantity 20,000
Value US$118,000
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
4.23
Quantity 60,092
Value US$254,189
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
3.97
Quantity 16,000
Value US$63,520
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
4.17
Quantity 16,000
Value US$66,640
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
4.51
Quantity 16,000
Value US$72,160
Keisari Yona Officer Officer
Transaction date
Proposed sale
Price
2.92
Quantity 22,602
Value US$65,998
Keisari Yona Officer Officer
Transaction date
Proposed sale
Price
2.81
Quantity 23,615
Value US$66,358
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.25
Quantity 3,393
Value US$14,420
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.60
Quantity 1,424
Value US$6,550
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.60
Quantity 7,471
Value US$34,366
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.70
Quantity 21,631
Value US$101,665
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.19
Quantity 60,000
Value US$251,532
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-25 2026-08-21 S Sale

Chief Financial Officer

Officer
59,473 +45.0%
20.93
US$344,799
59,473 +45.0% 20.93 US$344,799
2026-08-21 2026-08-21 PrS Proposed sale

Officer

Officer
56,121
364.41
US$162,617
56,121 364.41 US$162,617
2026-08-12 2026-08-11 S Sale

Chief Financial Officer

Officer
3,381 -45.8%
463.45
US$632,529
3,381 -45.8% 463.45 US$632,529
2026-07-07 2026-07-06 S Sale

Chief Financial Officer

Officer
2,270 -2.5%
14.00
US$31,782
2,270 -2.5% 14.00 US$31,782
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
20,000
13.23
US$264,600
20,000 13.23 US$264,600
2026-07-06 2026-07-02 S Sale

Chief Financial Officer

Officer
17,873 -16.5%
13.00
US$232,397
17,873 -16.5% 13.00 US$232,397
2026-07-02 2026-07-01 S Sale

Chief Financial Officer

Officer
2,127 -2.3%
13.02
US$27,691
2,127 -2.3% 13.02 US$27,691
2026-07-02 2026-07-01 PrS Proposed sale

Officer

Officer
20,000
12.58
US$251,600
20,000 12.58 US$251,600
2026-07-01 2026-06-30 S Sale

Chief Financial Officer

Officer
20,000 -18.2%
12.00
US$240,044
20,000 -18.2% 12.00 US$240,044
2026-06-30 2026-06-30 PrS Proposed sale

Officer

Officer
20,000
11.22
US$224,400
20,000 11.22 US$224,400
2026-06-26 2026-06-25 S Sale

Chief Financial Officer

Officer
15,778 -12.5%
11.00
US$173,561
15,778 -12.5% 11.00 US$173,561
2026-06-26 2026-06-25 S Sale

Chief Financial Officer

Officer
4,222 -3.2%
11.00
US$46,443
4,222 -3.2% 11.00 US$46,443
2026-06-26 2026-06-25 PrS Proposed sale

Officer

Officer
20,000
10.05
US$201,000
20,000 10.05 US$201,000
2026-06-25 2026-06-23 S Sale

Chief Financial Officer

Officer
2,500 -1.9%
10.00
US$25,001
2,500 -1.9% 10.00 US$25,001
2026-06-25 2026-06-23 S Sale

Chief Financial Officer

Officer
15,000 -10.2%
9.47
US$142,050
15,000 -10.2% 9.47 US$142,050
2026-06-23 2026-06-23 PrS Proposed sale

Officer

Officer
17,500
10.03
US$175,525
17,500 10.03 US$175,525
2026-06-04 2026-06-03 S Sale

Chief Financial Officer

Officer
15,000 -9.2%
10.76
US$161,356
15,000 -9.2% 10.76 US$161,356
2026-06-04 2026-06-03 S Sale

Chief Financial Officer

Officer
17,500 -9.7%
10.90
US$190,759
17,500 -9.7% 10.90 US$190,759
2026-06-04 2026-06-03 PrS Proposed sale

Officer

Officer
32,500
8.93
US$290,225
32,500 8.93 US$290,225
2026-02-26 2026-02-25 PrS Proposed sale

Officer

Officer
10,000
7.40
US$73,950
10,000 7.40 US$73,950
2026-02-02 2026-02-02 PrS Proposed sale

Officer

Officer
87,010
6.94
US$603,849
87,010 6.94 US$603,849
2026-01-14 2026-01-13 PrS Proposed sale

Officer

Officer
15,000
7.09
US$106,350
15,000 7.09 US$106,350
2026-01-12 2026-01-09 PrS Proposed sale

Officer

Officer
25,000
6.41
US$160,250
25,000 6.41 US$160,250
2026-01-09 2026-01-08 PrS Proposed sale

Officer

Officer
61,745
5.90
US$364,296
61,745 5.90 US$364,296
2026-01-09 2026-01-08 PrS Proposed sale

Officer

Officer
20,000
5.90
US$118,000
20,000 5.90 US$118,000
2025-12-11 2025-12-10 PrS Proposed sale

Officer

Officer
60,092
4.23
US$254,189
60,092 4.23 US$254,189
2025-12-01 2025-12-01 PrS Proposed sale

Officer

Officer
16,000
3.97
US$63,520
16,000 3.97 US$63,520
2025-11-03 2025-11-03 PrS Proposed sale

Officer

Officer
16,000
4.17
US$66,640
16,000 4.17 US$66,640
2025-10-01 2025-10-01 PrS Proposed sale

Officer

Officer
16,000
4.51
US$72,160
16,000 4.51 US$72,160
2024-03-15 2024-03-14 PrS Proposed sale

Officer

Officer
22,602
2.92
US$65,998
22,602 2.92 US$65,998
2023-12-18 2023-12-15 PrS Proposed sale

Officer

Officer
23,615
2.81
US$66,358
23,615 2.81 US$66,358
2023-06-09 2023-06-09 PrS Proposed sale

10% Stockholder

Large shareholder
3,393
4.25
US$14,420
3,393 4.25 US$14,420
2023-06-08 2023-06-08 PrS Proposed sale

10% Stockholder

Large shareholder
1,424
4.60
US$6,550
1,424 4.60 US$6,550
2023-06-08 2023-06-07 PrS Proposed sale

10% Stockholder

Large shareholder
7,471
4.60
US$34,366
7,471 4.60 US$34,366
2023-06-06 2023-06-06 PrS Proposed sale

10% Stockholder

Large shareholder
21,631
4.70
US$101,665
21,631 4.70 US$101,665
2023-06-02 2023-06-02 PrS Proposed sale

10% Stockholder

Large shareholder
60,000
4.19
US$251,532
60,000 4.19 US$251,532